Table 1.
| Table 1a Characteristics of 136 patients in our population-based study. | ||
|---|---|---|
| Characteristics | N/Total | % |
| Montefiore Medical Center | 57/136 | 41.9 |
| Jacobi Medical Center | 79/136 | 58.1 |
| Age at procedure | ||
| <30 | 24/136 | 17.7 |
| 30–45 | 80/136 | 58.8 |
| >45 | 32/136 | 23.5 |
| Race | ||
| Black | 56/118 | 47.5 |
| White | 10/118 | 8.5 |
| Hispanic | 36/118 | 30.5 |
| Other | 16/118 | 13.6 |
| Current smoker | ||
| Yes | 71/106 | 67.0 |
| No | 35/106 | 33.0 |
| Intravenous drug use | ||
| Yes | 21/99 | 21.2 |
| No | 78/99 | 78.8 |
| Parity | ||
| Multiparous | 44/48 | 91.7 |
| Nulliparous | 4/48 | 8.3 |
| Ever had an STD | ||
| Yes | 67/121 | 55.4 |
| No | 54/121 | 44.6 |
| Current hormone contraceptive use | ||
| Yes | 6/29 | 20.7 |
| No | 23/29 | 79.3 |
| Missed appointments | ||
| Rarely (0–3) | 39/89 | 43.8 |
| Frequently (3+) | 50/89 | 56.2 |
| Current HAART use | ||
| Yes | 57/111 | 51.4 |
| No | 54/111 | 48.7 |
| Table 1b Procedure and pathologic information for population-based study. | ||
|---|---|---|
| Characteristics | N/Total | % |
| First procedure type | ||
| LEEP | 93/136 | 68.4 |
| Cone | 43/136 | 31.6 |
| Procedure biopsy | ||
| CIN 1 | 61/136 | 44.9 |
| CIN 2 | 47/136 | 34.6 |
| CIN 3 | 28/136 | 20.6 |
| Margin status (endo- and ectocervical) | ||
| Both positive | 20/117 | 17.1 |
| Either positive | 49/117 | 41.9 |
| Both negative | 48/117 | 41.0 |
| CD4 count at time of procedure (±8 weeks) | ||
| ≤200 cells/µL | 38/114 | 33.3 |
| 201–500 cells/µL | 56/114 | 49.1 |
| >500 cells/µL | 20/114 | 17.5 |
| Viral load at time of procedure (±8 weeks) | ||
| Undetectable | 55/122 | 45.1 |
| Detectable –20,000 copies/mL | 35/122 | 28.7 |
| >20,000 copies/mL | 32/122 | 26.2 |